|
Eflornithine Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Alpha-Difluoromethylornithine, DFMO, Difluoromethylornithine, Difluromethylornithine, difluoromethylornithine
Birmingham, Alabama1 trial
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
University of Alabama/Children's of Alabama
Phase 2
Rochester, Minnesota1 trial
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Mayo Clinic in Rochester
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.